MLchartDataset catalogue

SB939

Term · Oncology and biomedicine · MLC-T-ONC-007564

A substance being studied in the treatment of several types of cancer. SB939 blocks the action of an enzyme called histone deacetylase (HDAC) and may stop tumor cells from dividing. It is a type of HDAC inhibitor.

Table 1. Record
IdentifierMLC-T-ONC-007564
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-007564",
  "term": "SB939",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of several types of cancer. SB939 blocks the action of an enzyme called histone deacetylase (HDAC) and may stop tumor cells from dividing. It is a type of HDAC inhibitor.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/sb939/"
}

Record 14,705 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.